期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

铜绿假单胞菌对碳青霉烯类抗生素耐药机制的研究进展 被引量：4

下载PDF
导出
摘要 近年来，随着抗菌药物的大量使用，多药耐药的铜绿假单胞菌（pseudomonasaeruginosa，PA）的数量和耐药率不断上升，其所导致的感染性疾病临床治疗十分棘手。PA对抗菌药物存在多种耐药机制，其主要机制是各种肛内酰胺酶的产生。本文就PA对碳青霉烯类抗生素的耐药机制作一综述。
作者 胡艳文
机构地区 天津市滨海新区塘沽妇幼保健院
出处 《山西医药杂志（上半月）》 CAS 2013年第6期637-639,共3页 Shanxi Medical Journal
关键词 碳青霉烯类抗生素 铜绿假单胞菌 耐药机制 抗菌药物 感染性疾病 多药耐药 临床治疗 内酰胺酶
分类号 R446.5 [医药卫生—诊断学]
  • 相关文献

参考文献12

  • 1李梅,潘发愤,周铁丽.多药耐药铜绿假单胞菌感染的危险因素分析[J].中华医院感染学杂志,2011,21(8):1593-1595. 被引量：16
  • 2王军,张建菊,刘华,唐权.铜绿假单胞菌致慢性阻塞性肺疾病患者肺部感染的危险因素及耐药性调查[J].中华医院感染学杂志,2011,21(3):457-458. 被引量：25
  • 3陈海荣,陈一强,温红侠,孔晋亮,蔡双启.生物膜形成相关的铜绿假单胞菌蛋白质组学研究[J].中华医院感染学杂志,2010,20(6):751-754. 被引量：18
  • 4Cardoso 0,Sousa JC,Leitao R,et al. Carbapenem-hydrolys-ing β-lactamase from clinical isolates of Pseudomonas aerugi-nosa in Portugal. J Antimicrob Chemother,1999,44:135.
  • 5Athanaassios T,Spyros P,Neil W,et al. Outbreak of infectioncaused by Pseudomonas aeruginosa producing VIM-1 carbap-enemase in Greece. J Clin Microbiol,2000,38-1290-1292.
  • 6Cornaglia G*Mazzariol A,Lauretti L,et al. Hospital outbreakof carbapenem-resistant Pseudomonas aeruginosa producingVIM-1,a novel transferable metallo-beta-lactamase. Clin In-fect Dis,2000,31(5):1119-1125.
  • 7Poirel L,Naas T,Nicolas D,et al. Characterization of VIM-2,a carbapenem-hydrolyzing metallo-(3-lactamase and its plasmidand integron-borne gene from a Pseudomonas aeruginosa clin-ical isolate in France. Antimicrob Agents Chemother,2000,44:891-897.
  • 8Toleman MA?Rolston K,Jones RN,et al. BlaviM-? ,an evolu-tionarily distinct metallo-beta-lactamase gene in a Pseudo-monas aeruginosa isolate from the United States. AntimicrobAgents Chemother,2004?48(1):329-332.
  • 9Livermore DM,Woodford N. Carbapenemases:a problem in-waiting. Curr Opin Microbiol,2000,3:489-495.
  • 10Murphy TA,Simm AM,Toleman MA,et al. Biochemicalcharacterization of the acquired,metallo-beta-lactamase SPM-1 from Pseudomonas aeruginosa. Antimicrob Agents Che-mother,2003,47(2)-582-587.

二级参考文献25

  • 1韩黎,朱士俊,郭燕红,李六亿,胡必杰,武迎宏,袁云娥.中国医务人员执行手卫生的现状调查[J].中华医院感染学杂志,2006,16(2):140-142. 被引量：631
  • 2Branda SS,Vik S, Friedman L, et al. Biofilms: the matrix revisited[J]. Trends Microbiol, 2005,13 (1) : 20-26.
  • 3Hanna SL, Sherman NE, Kinter MT, et al. Comparison of proteins expressed by Pseudomonas aeruginosa strains representing initial and chronic isolates from a cystic fibrosis patient:an analysis by 2-D gel electrophoresis and capillary column liquid chromatography-tandem mass spectrometry[J]. Microbiology, 2000,146 : 2495-2508.
  • 4Qiu D, Eisinger VM, Rowen DW, et al. Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa [J]. Proc Natl Acad Sci U S A,2007,104:8107-8112.
  • 5Reiling SA, Jansen JA, Henley BJ, et al. Pre protease promotes mucoidy in mucA mutants of Pseudomonas aeruginosa[J]. Microbiology, 2005,151 : 2251-2261.
  • 6Stapper AP, Narasimhan G, Ohman DE, et al. Alginate production affects Pseudomonas aeruginosa biofilm development and architecture, but is not essential for biofilm formation[J]. J Med Microbiol, 2004,53 : 679-690.
  • 7Arevalo-Ferro C, Hentzer M, Reii G,et al. Identification of quorum sensing regulated proteins in the opportunistic pathogen Pseudomonas aeruginosa by proteomics[J]. Environ Microbiol,2003,5(12) : 1350-1369.
  • 8Malhotra S,Silo-Suh LA, Mathee K,et al. Proteome analysis of the effect of mucoid conversion on global protein expression in Pseudomonas aeruginosa strain PAO1 shows induction of the disulfide bond isomerase, DsbA[J]. J Bacteriol, 2000, 182:6999-7006.
  • 9Hsueh PR,Tseng SP,Teng LJ,et al. Pan drug resistant Pseudo Monas aeruginosa causing nosocomial infection at a mxiversity hos pital in Taiwan [J]. Clin Microbiol Infect, 2005,11 (8) : 670-673.
  • 10Shan PS, Cannon JP, Sullivan CL, et al. cont rolling antimicrobial use and decreasing microbiological labortory tests for uri nary tract infections in Spinal ord-jury patients with chronic indwelling cat heters[J]. Am J Health Syst Pharm, 2005,62 (1) :74-77.

共引文献52

同被引文献75

  • 1黄仲义.美罗培南的药理学和临床应用[J].中国新药与临床杂志,2005,24(12):971-973. 被引量：16
  • 2邹豪,邵元福,朱才娟,邓渝林,马玉杰,陈盛新.医院药品DDD数排序分析的原理及利用[J].中国药房,1996,7(5):215-217. 被引量：1426
  • 3王永赓,钱广鸿.碳青霉烯类抗生素的比较及临床应用[J].基层医学论坛（B版）,2007,11(3):265-267. 被引量：13
  • 4Martone WJ, Gaynes RP, Horan TC, et al. National Nosocomial Infections Surveillance (NNIS) semiannual report, May 1995: A report from the National Nosocomial Infections Surveillance (NNIS) System[J]. Am J Infect Control, 1995,23(6) : 377 385.
  • 5Parker CM, Kuasoglannis J, Muscedere J, et al. Ventilator-associ ated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes[J]. J Crit Care,2008,23(1) :18 -26.
  • 6E1 Solh AA, Alhajhusain A. Update on the treatment of Pseudo- monas aeruginosa pneumonia[J]. J Antimicrob Chemother, 2009, 64(2) : 229-238.
  • 7Kirschke DL, Jones TF, Craig AS, et al. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufac- turing defect in bronchoscopes[J]. N Engl J Med,2003,348(3): 214-220.
  • 8Zavascki AP,Cruz RP,Goldani LZ. Risk factora for imipenem-re- sistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients [J]. J Hosp Infect, 2005,59(2) :96-101.
  • 9Kiratisin P, Chongthaleong A, Tan TY, et al. Comparative in vitro activity of carbapenems against major Gram negative pathogens: results of Asia-Pacific surveillance from the COMPACT Ⅱ study [J]. Int J Antimicrob Agents,2012,39(4) :311-316.
  • 10彭超,罗神敏.神经内科铜绿假单胞菌的耐药性分析[J].中外健康文摘,2014,11(22):296.

引证文献4

二级引证文献46

山西医药杂志（上半月）
2013年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部